Open Official source
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
National Institutes of Health
- Funding
- Up to $2.3M≈ €2M
- Deadline
- 30 Oct 2026Closes tomorrow
- Location
- United States
Overview
The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. The purpose of this Notice of Funding Opportunity is to establish the GREGoRi Technology Integration Center, which will enable the development of standards and best practices for applying new and emerging molecular methods in rare disease diagnosis. A major deliverable of the Center will be a multidimensional dataset that can be used for the development and benchmarking of novel tools and strategies that facilitate rare disease diagnosis.
Eligibility
Businesses are listed among eligible applicants.
Eligible applicants
- Independent school districts
- Small businesses
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Public housing authorities/Indian housing authorities
- State governments
- Special district governments
- Private institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
- Native American tribal governments (Federally recognized)
- City or township governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- County governments
- Public and State controlled institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Funding details
- Amount per award
- Up to $2.3M≈ €2M
- Currency
- USD
Important dates
- Published
- 18 Jun 2026
- Deadline
- 30 Oct 2026